Lack of alloimmunization to the D antigen in D-negative orthotopic liver transplant recipients receiving D-positive red blood cells perioperatively

Vox Sang. 2022 Aug;117(8):1043-1047. doi: 10.1111/vox.13282. Epub 2022 Apr 8.

Abstract

Background and objectives: D-negative patients undergoing orthotopic liver transplantation (OLT) might require a large number of red blood cell (RBC) units, which can impact the inventory of D-negative blood. The blood bank might need to supply these patients with D-positive RBCs because of inventory constraints. This study evaluates the prevalence of anti-D formation in D-negative OLT patients who received D-positive RBCs perioperatively, as this will assist in successful patient blood management.

Materials and methods: This was a retrospective study performed at a single academic medical centre. Electronic medical records for all 1052 consecutive patients who underwent OLT from January 2007 through December 2017 were reviewed. D-negative patients who were transfused perioperatively with D-positive RBCs and had antibody screening at least 30 days after transfusion were included.

Results: Of a total of 155 D-negative patients, 23 (14.8%) received D-positive RBCs perioperatively. Seventeen patients were included in the study. The median age was 54 years (range 36-67 years); 13 (76.5%) were male. The median number of D-positive RBC units transfused perioperatively was 7 (range 1-66 units). There was no evidence of D alloimmunization in any patient after a median serologic follow-up of 49.5 months (range 31 days to 127.7 months). The average number of antibody screening post OLT was 7.29.

Conclusion: Our study showed that transfusion of D-positive RBCs in D-negative OLT recipients is a safe and acceptable practice in the setting of immunosuppression. This practice allows the conservation of D-negative RBC inventory.

Keywords: D antigen; RBC transfusion; alloimmunization; blood management; liver transplant.

MeSH terms

  • Adult
  • Aged
  • Anemia, Hemolytic, Autoimmune*
  • Blood Transfusion
  • Erythrocytes
  • Female
  • Humans
  • Isoantibodies
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Isoantibodies